Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-389289

BioStem Technologies, Inc. · BSEM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Barry Hassett
Officer — Chief Commercial Officer
Period of report
Sep 9, 2026
Accepted (ET)
Sep 11, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001658678

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 9, 2026M500$0.00A5,003D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5—Sep 9, 2026M500D——Common Stock5004,497D
Stock Options (Right to Buy)F1$14.89holding————Feb 1, 2035Common Stock11,41711,417D
Stock Options (Right to Buy)F2$14.89holding————Oct 13, 2035Common Stock2,4272,427D
Stock Options (Right to Buy)F3$5.50holding————Feb 11, 2036Common Stock70,48570,485D
Restricted Stock UnitsF4,F6—holding—————Common Stock1,5191,519D
Restricted Stock UnitsF4,F7—holding—————Common Stock58,18258,182D

Explanation of responses